Advertisement

Topics

Former Tobira Executive Helen Jenkins Joins Alkahest as COO

18:42 EDT 8 Aug 2017 | Xconomy

San Carlos, CA-based drug developer Alkahest has appointed Helen Jenkins as chief operating officer. Jenkins served in the same role at Tobira Therapeutics, a South San Francisco, CA, biotech that was acquired last year by Allergan (NYSE: AGN). Alkahest is developing treatments for neurodegenerative diseases and other age-related conditions.

Original Article: Former Tobira Executive Helen Jenkins Joins Alkahest as COO

NEXT ARTICLE

More From BioPortfolio on "Former Tobira Executive Helen Jenkins Joins Alkahest as COO"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...